Psychiatry & Co-Morbid Medical Conditions: Renal (Q.2)

 

Psychiatry & Co-Morbid Medical Conditions: Renal

 

 

This question series will focus on clinically relevant questions related to the role of psychotropic medications in patients with underlying renal disease. 

 

(Q.1): Which of the following antipsychotic medication will need dosage adjustment in patient with schizophrenia and moderate renal impairment (eCrCl = 31-50 mL/min)?

  1. Paliperidone
  2. Olanzapine
  3. Clozapine
  4. Quetiapine

 

Answer =>  https://wp.me/p7Us3Y-gs

 

(Q.2): Which of the following mood stabilizer will NOT need dosage adjustment in patient with eCrCl of 25 mL/min?

  1. Lithium
  2. Depakote
  3. Oxcarbazepine
  4. Gabapentin
  5. Topiramate

Answer: 2. Depakote.

 

Depakote
  • A slight reduction (27%) in the unbound clearance of valproate has been reported in patients with renal failure (creatinine clearance < 10 mL/minute); however, hemodialysis typically reduces valproate concentrations by about 20%. Therefore, no dosage adjustment appears to be necessary in patients with renal failure.
  • Protein binding in these patients is substantially reduced; thus, monitoring total concentrations may be misleading.
Oxcarbazepine
  • In patients with creatinine clearance <30 mL/min: initiate at one-half the usual starting dose (300 mg/day, given twice-a-day) and increase slowly to achieve the desired clinical response.
Gabapentin
  • Creatinine Clearance > 60 : 900 to 3600 mg/day.
  • Creatinine Clearance >30-59: 400- 1400 mg/day.
  • Creatinine Clearance >15-29: 200- 700 mg/day.
  • Creatinine Clearance <15: 100-300 mg/day.
Topiramate
  • In renally impaired patients (creatinine clearance less than 70), one-half of the adult dose is recommended.
Lithium
  • Mild to moderate renal impairment (CLcr 30 to 89 mL/min): Start with low dose, titrate slowly with frequent monitoring
  • Severe renal impairment (CLcr < 30 mL/min): Avoid use of lithium.

 

Source: package insert for each medications mentioned above.


Please do post your questions or comments below. 


Dr. Harvinder Singh, M.D. (Admin)


Enroll in our online course to have access to all important clinically relevant psychiatry topics in one place.


Related Articles